G6PC1 and type 2 diabetes mellitus: G6Pase can control hyperglycemia because it determines the production of glucose released from gluconeogenesis and glycogenolysis [23]; therefore, inhibition of this rate-limiting enzyme is a target to treat hyperglycemia in T2D.